Bromday

Eye Pain, Cataract Surgery, Ocular Inflammation
Treatment
3 FDA approvals
6 Active Studies for Bromday

What is Bromday

BromfenacThe Generic name of this drug
Treatment SummaryBromfenac is a type of medication used to treat pain and inflammation in the eyes. It belongs to a class of drugs called non-steroidal anti-inflammatory drugs (NSAIDs). These drugs are becoming more commonly used to help manage ocular pain and inflammation and can help improve surgical outcomes.
Xibromis the brand name
image of different drug pills on a surface
Bromday Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Xibrom
Bromfenac
2005
19

Approved as Treatment by the FDA

Bromfenac, otherwise called Xibrom, is approved by the FDA for 3 uses including Ocular Inflammation and Eye Pain .
Ocular Inflammation
Eye Pain
Helps manage Eye Pain
Cataract Surgery
Helps manage Cataract Surgery

Effectiveness

How Bromday Affects PatientsBromfenac ophthalmic solution is a medicine used to treat the eyes that is both safe and not steroid-based.
How Bromday works in the bodyThe way this drug works is by blocking the production of prostaglandins. Prostaglandins are responsible for causing inflammation in the eyes, like increased pressure and extra blood flow. By blocking their production, the drug helps reduce these symptoms.

When to interrupt dosage

The prescribed dose of Bromday is contingent upon the diagnosed state, such as Cataract Surgery, Eye Pain and Ocular Inflammation. The amount likewise deviates according to the technique of administration (e.g. Solution / drops - Ophthalmic or Solution / drops) specified in the table beneath.
Condition
Dosage
Administration
Eye Pain
, 0.9 mg/mL, 1.035 mg/mL, 0.07 %, 0.7 mg/mL, 0.76 mg/mL, 0.75 mg/mL
, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic
Cataract Surgery
, 0.9 mg/mL, 1.035 mg/mL, 0.07 %, 0.7 mg/mL, 0.76 mg/mL, 0.75 mg/mL
, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic
Ocular Inflammation
, 0.9 mg/mL, 1.035 mg/mL, 0.07 %, 0.7 mg/mL, 0.76 mg/mL, 0.75 mg/mL
, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic

Warnings

Bromday Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Bromday.
Common Bromday Drug Interactions
Drug Name
Risk Level
Description
Valproic acid
Minor
The protein binding of Valproic acid can be decreased when combined with Bromfenac.
Aceclofenac
Moderate
The risk or severity of adverse effects can be increased when Bromfenac is combined with Aceclofenac.
Acemetacin
Moderate
The risk or severity of adverse effects can be increased when Bromfenac is combined with Acemetacin.
Acetylsalicylic acid
Moderate
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bromfenac.
Alclofenac
Moderate
The risk or severity of adverse effects can be increased when Bromfenac is combined with Alclofenac.
image of a doctor in a lab doing drug, clinical research

Bromday Novel Uses: Which Conditions Have a Clinical Trial Featuring Bromday?

7 active trials are assessing the potential of Bromday to alleviate Cataract Surgery, Eye Pain and Ocular Inflammation.
Condition
Clinical Trials
Trial Phases
Eye Pain
2 Actively Recruiting
Not Applicable, Phase 4
Cataract Surgery
1 Actively Recruiting
Phase 4
Ocular Inflammation
3 Actively Recruiting
Phase 2, Phase 4, Phase 3

Patient Q&A Section about bromday

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Prolensa an NSAID?

"PROLENSA® is a nonsteroidal anti-inflammatory drug (NSAID) that is indicated to treat inflammation and reduce eye pain in patients after cataract surgery."

Answered by AI

Who makes bromday?

"The Food and Drug Administration approved Ista Pharmaceuticals' new non-steroidal anti-inflammatory drop Bromday 0.09% (bromfenac ophthalmic solution) for use after cataract surgery in October. This makes it the first q.d. NSAID approved for this indication."

Answered by AI

What is bromfenac 0. 09% used for?

"The drug Bromday, which is a solution used to drop into the eye, is intended to help with swelling and pain relief after surgery for those who have had cataracts removed."

Answered by AI

What are the side effects of Bromfenac eye drops?

"There are several potential symptoms associated with poor eye health, including blurred vision, changes in color vision, decreased vision, difficulty seeing at night, and eye pain. Other signs that something may be wrong with your eyes include red, sore eyes, sensitivity to light, and tearing. If you experience any of these symptoms, it's important to consult an eye doctor to rule out any serious problems."

Answered by AI

Clinical Trials for Bromday

Have you considered Bromday clinical trials? We made a collection of clinical trials featuring Bromday, we think they might fit your search criteria.